129 19 514MB
English Pages 713 [481] Year 2023
PRECLINICAL
IMMUNOLOGY
AND
MICROBIOLOGY
REVIEW
2023
® FOR
USMLE
STEP
1
AND
® COMLEX
USMLE®
USA
and
the
Federation
do
not endorse,
(NBOME),
United
States
of State which
this
Medical
Medical
Licensing
Boards
product.
COMLEX
is not affiliated
with
LEVEL
Examination®
(FSMB),
which
are
USA® is a registered Kaplan
and
was
not
is a joint not
1
program
affiliated
trademark involved
in the
with of the
of the Kaplan National
production
National and
Board
were Board
of, and
not
of Medical
involved
of Osteopathic does
not
endorse,
Examiners
in the
production
Medical this
(NBME)
Examiners, product.
and
of, and Inc
PRECLINICAL
IMMUNOLOGY
AND
MICROBIOLOGY
REVIEW
2023
FOR
USMLE®
STEP
COMLEX
USA®
USMLE® and of State COMLEX was
1
United
Medical
States
Boards
Medical
(FSMB),
USA® is a registered
not involved
in the production
Licensing
are not affiliated
trademark
of the National
of, and
does
LEVEL
Examination®
which
AND
is a joint program
with Kaplan Board
not endorse,
and
were
of Osteopathic
this product.
1
of the National not involved Medical
Board
of Medical
in the production
Examiners,
Examiners
of, and
Inc. (NBOME),
(NBME)
do not endorse, which
and the Federation this product.
is not affiliated
with Kaplan
an
USMLE®
and
(NBME) the
United
and
the
production
COMLEX not
of,
USA®
with
publication
date,
with
medical,
and
is a
affiliated
This
States
the
of
a
of
medical
and/or
1515
10
7
Course
ISBN:
Course
Kit
Retail
ISBN:
Retail
Kit
Kit
items
Kaplan or
978 ISBN:
ISBN:
978
come
as
Publishing
educational
department
1
2
1
5062 1
866
Board
Kaplan
of
and
Medical
were
Examiners
not
involved
(NBOME),
which
in
practice
sought.
This
the
neither
out
of
does
to
or
the
legal
the
subject
is
to
any
product.
covered
publisher
or
not
other
is
of
for
the
as not
expert
intended nor
use
Inc.
this
matter The
Publisher
Examiners,
endorse,
advice
publication
related
not
evolve.
or
of
law,
Medical
and
constantly
If medical
be
arising
Osteopathic of,
material
reproduced
in
its
use
in
assume
publication
engaged
in
assistance
Editors
the
of
is
rendering
is required,
clinical
practice
any
liability
contained
in this
manner
whatsoever
or for
any
book.
LLC
this
of
Kaplan
publication,
North
America,
LLC.
8449
any
thereof,
may
part
not
be
any
without
5062
1 8465
8447 5062
8463
print
books
are
For
more
1949
1
7
and
506
or
publisher.
a set
purposes. at
National with
1
5062
978
978
of
the
3
1
best
extent
property
a division
text
from
4
the
33309
The
5
of affiliated
Road
Florida
6
not
in regard
service.
should
or
America,
Creek
reserved.
8
persons
Medical,
Cypress
and
fullest
program are
of
production
information
professional
To the
joint
which
Board
in the
knowledge
other
National
accurate
professional
to
the
involved
provide
is a
(FSMB),
product.
of
not
that or
care.
Kaplan
permission
9
to
North
Lauderdale,
written
was
Examination® Boards
this
trademark
competent
Kaplan
by
All rights
endorse,
and
damage
West
Fort
not
accounting,
delivery
by
State
understanding
services
Published
Medical
is designed
legal,
2023
Licensing
of
registered
the
©
do
Kaplan
the
injury
Medical
Federation
should
7
not
be
available information
broken
at
out
special or
to
and
quantity purchase
sold
separately.
discounts books,
to please
use call
for the
sales Simon
promotions, & Schuster
employee special
premiums, sales
Editors
Immunology
Tiffany Chief
L.
Resident,
University
of
Alley,
DO,
Department
Tennessee
PhD of
Graduate Knoxville,
Pathology
School
of
Medicine
TN
Microbiology
Christopher Professor
and Lake
C.
Director Erie
College
of
Keller,
Microbiology of
Erie,
Osteopathic P
PhD and
Immunology
Medicine
We
want
to
hear
what Please
you email
think. us
What at
do
you
like
[email protected]
or
not
like
about
the
Notes?
Table
PART
I:
of
Contents
IMMUNOLOGY
CHAPTER
1:
The
Immune
CHAPTER
2:
Ontogeny
CHAPTER
3:
Lymphocyte
CHAPTER
4:
Periphery:
Innate
CHAPTER
5:
Secondary
Lymphoid
of
Innate
CHAPTER
6:
System
the
.
.
.
Immune
Secondary
.
Cells
Development
and
Immune
Immune
B and
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Selection
Response
.
Lymphoid
Meets
Adaptive
Activation
7:
Humoral
CHAPTER
8:
Cell
CHAPTER
9:
Immunodiagnostics
CHAPTER
10:
Immunizations
CHAPTER
11:
Primary
CHAPTER
12:
Hypersensitivity
and
CHAPTER
13:
Transplantation
.
.
.
.
.
.
.
I:
APPENDIX
II:
IMMUNOLOGY
ANSWERS
CD
Immunity.
.
EXPLANATIONS
.
.
.
3
.
.
.
.
.
.
7
.
.
.
.
.
.
13
.
.
.
.
.
.
.
27
.
.
.
.
.
.
.
.
49
.
.
.
.
.
.
.
57
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
71
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
77
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
85
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
99
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
109
.
.
.
.
.
.
.
.
.
.
.
113
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Immunodeficiencies
PRACTICE
AND
.
Immunity
Markers
Cytokines
.
.
CHAPTER
APPENDIX
.
Tissue:
T Lymphocyte
.
.
Tissue:
Response
Mediated
.
.
.
.
Autoimmune
Disease
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
123
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
127
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
129
QUESTIONS
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
133
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
145
PART
II:
MICROBIOLOGY
CHAPTER
1:
General
CHAPTER
2:
Medically
CHAPTER
3:
Bacterial
CHAPTER
4:
Medically
Relevant
Viruses
CHAPTER
5:
Medically
Relevant
Fungi
CHAPTER
6:
Medical
CHAPTER
7:
Clinical
CHAPTER
8:
Comparative
APPENDIX
I:
INDEX
v
.
.
.
.
.
.
.
.
.
Parasitology
Infectious
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
. 167
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
. 179
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
. 247
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
. 269
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
. 325
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
. 341
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
. 357
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
. 381
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
. 393
.
.
Disease
Microbiology
Charts
and
.
.
Tables
QUESTIONS
EXPLANATIONS
.
.
Bacteria
Genetics
PRACTICE
AND
.
Relevant
Reference
MICROBIOLOGY
ANSWERS
Microbiology
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.411
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.443
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.455
PART
IMMUNOLOGY
The
LEARNING
Define
❏
Discriminate
describe
immune
The
system
is
immune
designed
to
of
and
the
immune
acquired
recognize it
distressed,
system
is
immune
Innate
innate
Additionally,
damaged,
adaptive
components
between
manner.
diseased,
the
system
immunity
SYSTEM
coordinated
or
divided
and
recognizes
respond and
to
non
eliminates
self cells
antigen that
in
are
dying.
into
2 complementary
arms:
the
innate
and
the
systems.
Immunity
Innate It
and
IMMUNE
The
System
OBJECTIVES
❏
THE
Immune
immunity
involves
provides
several
•
Anatomic
•
Physiologic
•
Complement
•
Cellular:
•
Inflammation
Innate
and
Are
•
Have
•
present
molecular
patterns
Are
limited
Adaptive
not
the
anti
defense
against
membranes
infectious
and
microbials
following
with
specificity associated
of
agents.
and
normal
flora)
cytokines)
granulocytes
intrinsically
limited
line
mucous
pH,
have
(pathogen
first
(skin,
and
defenses
for
or shared
molecular
characteristics
without
in
previous
microbe patterns
and [PAMPs]
common:
stimulation cellular
structures
and
damage
associated
[DAMPs])
diversity
recognition •
physical
phagocytes
Have
body’s barriers:
(temperature,
immune
•
the
defensive
as
reflected
by
a limited
number
of
pattern
receptors enhanced
in
activity
upon
subsequent
exposure—no
memory
Immunity
The
components
their
effector
of cells.
the
adaptive
immune
response
are
B and
T
lymphocytes
and
a
1
PART
I
|
IMMUNOLOGY
Adaptive
immune
defenses
•
Each
•
As
•
Are
enhanced
•
Are
capable
•
Are
self
The
B and a
of
is
characteristics
specific
for
have
each
repeat
a
particular
extensive
self
common:
antigen
diversity
exposure
distinguishing
in
—immunologic
from
non
memory
self
limiting
of
adaptive
immunity
against
Specificity
is
against •
following
lymphocytes with
defense
•
the
lymphocyte
population,
features
possible
T
have
required,
persistent
Diversity
is
are
designed
to
give
the
individual
the
best
disease.
along
or
with
recurrent
required
to
immunologic
memory,
to
protect
challenge.
protect
against
the
maximum
number
of
potential
pathogens. •
Specialization
of
defense •
The is
•
can
be
ability vital
Self
to
in
I 1
distinguish
1.
the
conserve
versus
in
Characteristics
to
and
(host
return
cells)
to
resources
leukemia
Adaptive
so
or
and
For
the
and
non
a
basal to
self
(pathogens)
resting avoid
state
after
a
uncontrolled
cell
Adaptive
pathogen
associated
For
patterns
specific
antigens
microbial
of
and
(PAMPs)
nonmicrobial
Diversity
Limited
High
Memory
No
Yes
No
No
reactivity
effective
Immunity
molecular
Self
most
lymphoma.
Innate
Specificity
that
challenges.
response.
system
energy
necessary
self
autoimmune
resulting
Innate
is diverse
between an
allows to
proliferation
Table
function against
inhibiting
limitation
challenge
effector
mounted
agents
Components
Anatomic
and
physiologic
barriers
Skin,
mucosa,
flora,
temperature,
normal
Lymph pH,
antimicrobials,
and
nodes,
spleen,
mucosal
associated
lymphoid
tissues
cytokines
Blood
proteins
Complement
Cells
Antibodies
Phagocytes, and
granulocytes
natural
killer
(NK)
B
lymphocytes
T
lymphocytes
and
cells
Function The
innate
stop
an
ologic able
to
and
adaptive
infection.
arms
Once
of
a pathogen
barriers,
the
innate
contain
and
eliminate
immune the
the
immune has response
infection.
broken
response through is immediately
work the
in
collaboration
anatomic activated,
to
and
physi
oftentimes
CHAPTER
When
the
innate
pathogen, immune the
immune
the response
primary
in
an
Once
an
cease.
Antibodies
while
memory
the
infection
has and cells
unable
to
response
antigen
for
through
is
immune
infection
infection
response
adaptive
the
is
specific
of
been
cleared,
residual
both
effector
provide
long
term
and
the
cells
it
response
cells
replication
of
activated
Typically,
immune
effector
the and
manner.
adaptive
action
control
engaged
to
by
takes
1–2
begin
a
the
innate weeks
clearance
after of
the
antibodies.
innate
and
continue
to
immunologic
adaptive provide
immune
responses
protective
protection
immunity,
from
subsequent
infection.
2 4
1 Innate
Induction 3
immune
of
response
Level
Immunological
adaptive Adaptive
response
immune
response
memory
of
microorganism
Antigen’s
threshold
level
to
activate
adaptive
immune
response
Duration Entry
of
infection
of
Pathogen
cleared
microorganism
FFigure igure
The
innate
another;
•
and rather,
they
Phagocytic pattern
•
adaptive
by
and
present
Immune Response
act
Response to an Acute
independently
of
to Infection an
one
by
binding
to
phagocytosis.
antigen
PAMPs
to release
through
facilitate of
various
stimulation
cytokines
that
of trigger
responses.
cytokines
that
enhance
microbicidal
activities
phagocytes. •
Cytokines tiation
•
Antibodies complement
released of
B
by
phagocytes
lymphocytes will
aid
activation
into in
Acute
mechanism.
subsequent
immune
produce
not
feedback
leading
with
of Immune the
do
pathogens
process
specific
lymphocytes
a positive
receptors
lymphocytes of
responses
recognize
cells T
initiation T
work
cells
specific
•
immune
recognition
Phagocytic
I 1 I 1.1 Timeline 1. Timelineof the
the and
and plasma
destruction antibody
T
lymphocytes
cells of
and pathogen
dependent
will isotype
drive
differen
switching. through
cellular
opsonization, cytotoxicity.
of
Infection
1
|
THE
IMMUNE
SYSTEM
PART
I
|
IMMUNOLOGY
Anatomic
and
Physiologic
Barriers
Immune Respons Phagocytes
and
Complement
Granulocytes
Innate
Cytokines
Immune
Antibodies
Response
T
Adaptive
Lymphocytes
B
Lymphocytes
Cytokines
Figure
I 1
Figure I 1 2. Interaction
2. Interaction between
Recall
Question
Which
of
the
immunologic
between Innate and Adaptive Innate and Adaptive
following
is most
response
re
exposure?
A.
Innate
B.
Natural
killer
C.
Innate
immunity
likely
against
immunity,
as
to
the
adaptive
cause
same
immunity
Immune Immune
Responses Responses
a faster infectious
takes
and
stronger
agent
1–2
after
weeks
cells
because
macrophages
recognize
PAMPs
and
DAMPs
D.
Adaptive
E.
Complement
immunity
and
immunological
memory
activation
Answer:
6
D
Ontogeny
LEARNING
❏
the
Immune
Cells
OBJECTIVES
Explain
information
immune
❏
of
Explain
related
to
origin
related
to
antigen
and
function
of
cells
of
the
system
information
recognition
molecules
of
lymphocytes
❏
Answer
questions
about
the
generation
of
receptor
diversity
ORIGIN Hematopoiesis tion
of
involves
the
multipotent
During
blood stem
the
cells.
The
and Once
and
finally,
production,
site
early
the
bone
differentiation,
megakaryocytes of
the
hematopoiesis
where
Figure
it
will
I 2 1.
yolk
sac
Sites
matura
from
during
shifts remain
and
leukocytes)
changes
development, begins,
marrow
and
hematopoiesis
fetal
organogenesis to
development,
(erythrocytes,
embryogenesis
hematopoiesis. spleen,
cells
development.
is to
throughout
of Hematopoiesis
the the
site liver
of and
adulthood.
2
PART
I
|
IMMUNOLOGY
These
multipotent
undergo population
of
common
stem
The
cells
The
common
in
The
(self
cell stem
common
bone
the
or
a
cells
to
lymphoid and
the
of
renewal),
response
lymphocytes
in
One
multipotent
cells
•
found
progenitor
myeloid
•
cells
division.
lymphoid
(potency). and
stem
asymmetric
daughter
while
the
will
myeloid
give
renew
the
either
a
rise
into
to
rise
cell
the
various
growth
gives
cell
gives
cells,
and
to
to
lymphoid
factors.
to
B
lymphocytes,
T
cells.
progenitor
monocytes/macrophages
ability
serve
progenitor
and
cell (NK)
mast
can
differentiate
progenitor
karyocytes/thrombocytes,
other
the
will
myeloid
cytokines
killer
have cells
common
various
natural
marrow
2
rise
to
eosinophils,
dendritic
erythrocytes,
mega
basophils,
neutrophils,
cells.
FUNCTION The
white
functions Cells
of
non
the
blood
cells
of
in
body
once
the myeloid
specific,
immune
from
stereotypic
and
T
cell
the
of
the of
immunity. in
in
bloodstream
the
microscopic
perform branch
lymphoid
Natural immunity.
specialized
is complete.
innate
the
innate
light
have
marrow
megakaryocytes,
members
in
cells
bone
and
lymphocytes at
stem
the
lymphocytes
participate
indistinguishable
2 interdependent
T
roles
but
and
lymphoid in
are
and
specific
B lymphocytes
and
erythrocytes
lymphocytes
lineage
morphologically
•
except
antigen
lymphoid
Although
myeloid differentiation
responses B
focused, the
the their
lineage,
response.
perform
both
killer
cells
are level,
of
the
lineage are
also
almost
they
represent
lineages.
B lymphocytes
remain
within
the
bone
marrow
to
complete
their
development. •
T
lymphocytes
the
Both
B and
specific
leave
T
lymphocytes
antigens;
•
the
bone
marrow
and
undergo
development
within
thymus.
The granular through
the
natural
have
killer lymphocyte non
surface
generation
specific
(NK)
of
these
cell
(the
that binding.
recognizes
membrane
receptors
receptors
third
will
type tumor
of and
be
designed discussed
lymphocyte) virally
to in
is infected
bind
chapter
a large cells
to 4.
CHAPTER
In
2
|
ONTOGENY
T
cell
progenitor
T
stem IL
CELLS
lymphocyte
Thymocyte
Cytotoxic
Lymphoid
IMMUNE
Thymus
Helper
NK
OF THE
B
B progenitor
Lymphocyte
T
Plasma
lymphocyte
cell
cell
7
Multipotent
stem
cell
Dendritic
cell
Monocyte
Granulocyte/ Monocyte GM
CSF,
IL
Macrophage Neutrophil
progenitor
3
IL
IL
5
5 Eosinophil
Eosinophil
progenitor
Myeloid stem
Mast
cell
cell
Basophil
Thrombopoietin
Basophil progenitor
Erythropoieti IL
11
Megakaryocyte
Erythroid
Figure
I 2 Figure
Platelets
progenitor
I2. 2 2.Ontogeny Ontogeny
Erythrocytes
Immune ofof Immune
Cells Cells
9
PART
Table
I 2
Myeloid
1.
I
|
White
Cell
Neutrophil
Blood
Cells
Tissue
or
polymorpho nuclear
IMMUNOLOGY
Most
Location
Physical
abundant
circulating
blood
cell
(PMN)
with
segmented,
lobular lobes)
Lymphocyte
Tissue
Location
Bloodstream, lymphoid
Physical
secondary tissues
small
extracellular
activity
aimed
at
killing
pathogens
pink
granules
dark a
Function
staining
thin
Surface B
Phagocytic nuclei
Description
Large, with
a
and
cytoplasmic
Cell
Function
Granulocyte
(3–5
cell
Lymphoid
Description
rim
nucleus
of
cytoplasm
No
function
until
activated
secondary
lymphoid
Terminally
differentiated
in
the
tissues
markers: lymphocytes
T
CD19,
20,
21
lymphocytes -
CD3
Helper -
T
cells
CD4
CTLs -
Plasma
cell
Bloodstream, lymphoid bone
Natural cell
killer
Bloodstream
secondary tissue
marrow
and
CD8
Small
eccentric
intensely
nucleus,
staining
Golgi
lymphocyte
that
B
secretes
antibodies
apparatus
Lymphocyte
with
cytoplasmic
granules
Surface CD16,
large
Kills
virally
infected
cells
and
tumor
cells
markers: 56
(Continued
1
)
CHAPTER
Table
I 2 1.
Myeloid
White
Cell
Blood
Location
Physical
Circulating
blood
cell
Reside
in
all
Description
Agranulocyte kidney
Macrophage
|
ONTOGENY
OF THE
IMMUNE
CELLS
Cells
Tissue
Monocyte
2
tissues
Function
with shaped
Agranulocyte
a
bean
or
Precursor
of
tissue
macrophage
nucleus
with
cytoplasmic
membrane
cytoplasmic
vacuoles
a
ruffled
•
Phagocyte
•
Professional
and antigen
presenting
antigen
presenting
large
extracellular
large
extracellular
large
extracellular
and cell
vesicles
Dendritic
cell
Reside and
in
epithelial
lymphoid
Agranulocyte
tissue
stellate
with
thin,
•
T cell
activator
•
Phagocyte
•
Professional
cytoplasmic
projections cell
Eosinophil
Circulating
blood
recruited
Mast
cell
into
connective
tissue
respiratory
and
Reside
in
adjacent
cell
most to
nucleus of
GI
Low
the
with and
cytoplasmic
tissues
blood
Granulocyte nucleus
frequency
with and
•
Elimination
pink
of
parasites •
Type
I hypersensitivity
cell
nucleus cytoplasmic
large
small
•
Elimination
blue
of
parasites
granule
Granulocyte blood
bilobed
activator
granules
cytoplasmic
circulating
large
T cell
tracts
vessels
Basophil
Granulocyte
loose
•
with and
large
bilobed
•
Type
•
Elimination
blue
I hypersensitivity
of
parasites
granules •
Type
I hypersensitivity
1
PART
I
|
IMMUNOLOGY
Laboratory
evaluation
of
patients
cell
morphology
and
relative
the
morphology
and
proportions
some
pathologic
band
cells,
Cell
A
lymphocytes
eosinophils
Table
state.
and
I 2
2.
commonly counts of
standard (B
by white
white
lymphocytes,
assessment of
blood blood T
cells cell
of
a blood indicate
differential
lymphocytes,
the
Leukocytes
Evaluated
in
a WBC
NK
cells),
Range
(%)
Differential
Adult
Neutrophils
(PMNs)
Reference
50–70
cells
0–5
Lymphocytes
20–40
Monocytes
5–10
Eosinophils
0–5
Basophils
55
with
transplant
high
alcohol
intake;
immunosup
patients
intracellular
pathogen;
endotoxin
Disease(s) •
Legionnaires ing mental
•
disease
systems
(“atypical
(now
confusion;
Pontiac
pneumonia”):
routinely diarrhea
fever:
associated
decontaminated); (no
pneumonitis;
no
with
pneumonia;
Legionella
in
GI
air
condition
hyponatremia;
tract)
fatalities
Diagnosis •
Urinary
•
DFA
•
Fourfold
antigen (direct
Treatment:
test
(serogroup
fluorescent
increase
antibody)
in
(levofloxacin)
(immunocompromised
Prevention:
routine
GENUS:
on
biopsy,
(+)
by
Dieterle
silver
stain
antibody
fluoroquinolone
rifampin
1)
or
patients);
decontamination
macrolide
drug
of
air
(azithromycin)
must
penetrate
conditioner
with human
cooling
cells.
tanks
KEY
FRANCISELLA
VIGNETTE
Francisella
Francisella
tularensis
•
Hunter atypical
Distinguishing
Features
•
Small
gram
•
Potential
•
Zoonosis
Reservoir: endemic
every
with
ulceroglandular
pneumonia,
•
Arkansas/Missouri
•
Exposure
disease, or
GI
disease
to
rabbits,
ticks
agent
species state
tularensis
rod
biowarfare
many in
negative
CLUES
of of
the
wild U.S.
animals, but
especially highest
in
rabbits, Arkansas
deer, and
and
rodents;
Missouri
21
Pathology
BehavioralScience/Social Sciences
PART
II
|
MICROBIOLOGY
Microbiology Transmission •
•
Tick
bite
ulcer
at
(Dermacentor) bite
site,
Traumatic
→
and
ulceroglandular
regional
disease,
lymph
implantation
while
node
characterized
enlargement
skinning
and
rabbits
→
by
fever,
necrosis
ulceroglandular
disease •
Aerosols
(skinning
•
Ingestion
(of
typhoidal
tularemia.
Pathogenesis: cells);
bite);
facultative
VIGNETTE
Bordetella
•
or
contaminated
pathogen
tularemia tularemia
Diagnosis:
serodiagnosis
Treatment:
streptomycin
(open
(culture
tick
those
atypical
is
against (for
wound
(bioterrorism;
protection vaccine
GENUS:
meat
water)
(localizes
in
contact
with
produces
reticuloendothelial
at
hazardous);
bites;
high
DFA;
glove
rabbit
blood;
Unvaccinated
child
religious
Cough
(immigrant
use
grows
while
on
BCYE
butchering
rabbits;
risk)
BORDETELLA
Genus
family
objections)
with
inspiratory
“whoop”
Features •
Gram
•
Strict
Species
NOTE
negative
Immunity
rods
aerobes
of
Medical
Bordetella
B. pertussis
small
Importance:
Bordetella
pertussis
pertussis
Distinguishing
Features:
small
gram
negative,
aerobic
rods;
encapsulated
organism •
Vaccine is
immunity
primarily
•
Babies
•
Vaccinated
lasts
5–10
yrs
(and Reservoir:
IgA)
born
with
little
humans
immunity
>10
yrs
human
Transmission:
serve
(vaccinated)
respiratory
droplets
as Pathogenesis
reservoir
•
12–20% >2
•
Vaccine
•
Acellular
of wks
afebrile
have
(DTaP
adults
with
•
B.
pertussis
•
Attachment
is
pertussis
to
hemagglutinin;
vaccineDTaP)
•
Toxins –
Components:
immunogens
manufacturer;
pertussis
filamentous (OMP)
21
hemagglutinin;
vary
surface
pathogen
cough nasopharyngeal
ciliated
pertussis damage
Adenylate phagocytosis
•
mucosal
toxin
respiratory cyclase and
(on
epithelial
outer
cells
membrane)
is aids
via in
filamentous attachment
epithelium. toxin:
causes
impairs local
leukocyte
chemotaxis
→
inhibits
edema
by
toxoid; pertactin
–
Tracheal
–
Endotoxin
cytotoxin:
interferes
with
tick
pneumonia)
pertussis
or
•
CLUES
infected
intracellular
ulceroglandular
attenuated
pneumonia
response
pneumonic
Prevention:
→
undercooked,
granulomatous
Disease:
KEY
rabbits)
ciliary
action;
kills
ciliated
cells
live,
CHAPTER
–
Pertussis
toxin
ation
of
with
Gi
(A
and
(inhibiting
transfer
of
lymphocytosis;
component,
negative
signals islet
immune
B
effector
protein
regulator
from
cell
activation
cells
OM of
surface
(decreased
adenylate
to
leading
to
toxin):
ADP
chemotaxis);
RELEVANT
BACTERIA
system:
blocking
increased
MEDICALLY
interferes
mediator
hypoglycemia;
|
ribosyl
cyclase)
intracellular
2
of
histamine
sensitivity
Table
II 2
18.
Stages
of
Whooping
Cough
(Pertussis)
Incubation
Duration
7–10
Symptoms
None
vs.
Results
of
Catarrhal
days
1–2
weeks
Rhinorrhea,
Culture
Paroxysmal
Convalescent
2–4
3–4
weeks
Repetitive
malaise,
sneez
ing,
Bacterial
cough
whoops,
anorexia
vomiting,
leukocytosis
with
weeks
Diminished
longer)
paroxysmal
development
of
complications seizures,
Bacterial
(or
cough,
secondary (pneumonia,
encephalopathy)
Culture
Diagnosis •
Fastidious/delicate: cough
•
Difficult
•
Direct
•
PCR
14
or to
culture
and
days
tests
care,
Prevention:
all
vaccine toxoid);
immunity
middle
GENUS:
DTaP
from
Gengou
media;
either
direct
of
paroxysmal on
stage
on
nasopharyngeal
smear
available
i.e.,
hospitalization
household
immunity
(IgA)
Bordet
(DFA)
serologic
including
or
cultures
from
supportive
pertussis
Lowe
nasopharyngeal
immunofluorescence
Treatment: for
Regan
plates
if
age
1:160
rifampin
cotrimoxazole
KEY
is
antibodies
agar near
factors
S.
agar
human
X
(hemin)
and
V
(NAD)
(BA) aureus
provides
on
BA
both
=
X
“satellite”
and
V
phenomenon
factors
nasopharynx
respiratory
droplets,
shared
toys
for
growth
on
nutrient
CHAPTER
2
|
MEDICALLY
RELEVANT
BACTERIA
Pathogenesis •
Polysaccharide
capsule
important •
Capsule
IgA
important
in
diagnosis;
serotype
protease
b capsule
is polyribitol
phosphate)
most
factor
agglutination); •
(type
virulence
is a
antigen
all
mucosal
isolates
screen
by
colonizing
on
CSF
(e.g.,
latex
particle
quellung. factor.
Diseases •
Meningitis –
Epidemic
–
After
in
unvaccinated
maternal
children
antibody
has
ages
waned
and
3
months
before
to
2
years
immune
response
of
child
is adequate –
Up
to
1990,
(mainly •
Otitis
•
Bronchitis:
•
Pneumonia:
•
Epiglottitis:
media:
Diagnosis:
still
usually
was
rare
blood
Treatment:
or
if
CSF
common
child
cause
age
2,400
•
S.
typhi
•
S.
enteritidis
•
S.
typhimurium
•
S.
choleraesuis
•
S.
paratyphi
•
S.
dublin
Importance serotypes
of
Salmonella.
or
third
present
tract
catheter
generation
cephalosporin
for
CHAPTER
Salmonella
enterica
2
KEY
typhi
|
VIGNETTE
Salmonella Distinguishing
Features
•
Gram
negative
•
Facultative
•
Produces
•
Species
•
Sensitive
rods,
highly
anaerobe,
motile
with
non–lactose
the
Vi
MEDICALLY
CLUES typhi
•
Patient
with
•
Travel
to
•
Gram
(
biochemical
Reservoir:
only;
fecal
stomach
acid
or
predisposes
Pathogenesis
Infection
•
Host
•
Salmonella
S.
S.
in
•
Symptoms: than
•
3:
Prevention: (Ty21a), ViCPS
bladder); sickle
fever),
S.
gas
Widal
test
decreased
cell
disease
typhi
(milder
form:
of
common
Salmonella M
positive
contact.
cells,
then
blood
septicemia
mesenteric
lymph
nodes
(proteins)
have
rose
spots
in
macrophages;
fusion allow
of
it
to
resistant
lysosomes
to
with
withstand
oxygen
killing
cultures
headache,
25%
fever)
replicates
decreased
independent stool
cultures;
(mainly
and of
defensins
85%
Complications
Diagnosis:
Treatment:
of
oxygen
fever,
if
endotoxin
monia,
patient’s
H2S
are
positive
abdominal
pain,
constipation
more
common
diarrhea
(local
biopsy
80%
because
and
week
in
constipation
of
intracellularly killing
and
By
produces
nonlactose
septicemia)
have
survives
•
side
19
signs
dependent
as
(enteric
from
basolateral
patients
phagosomes
(gall
cells
region;
“ruffle”
reach
macrophage
carriers
fever
ileocecal
(transient
1 week:
human
mononuclear
typhoid
membranes
typhi
), encapsulated,
paratyphi)
(trunk/abdomen), •
area
infection
Disease:
blood
At
endemic
reservoirs
from of
begins cell
and
animal
route
Salmonella
fever;
•
•
oral
and
paratyphoid
no
impairment
to
pain
acid
humans
Transmission:
abdominal
reactions •
to
fever,
fermenting
fermenter, with
BACTERIA
capsule
H2S identification
RELEVANT
abscess
the
serum
can
rose can
necrosis
be
if
isolated
sanitation;
detected
polysaccharide
with
perforation
cholecystitis,
typhi
generation
(no
O,
marrow, Vi,
and
(Widal
(attenuated S.
bone to
agglutination
third
vaccines killed
capsular
patches
blood,
antibodies
by
or
3 heat
from
present;
fluoroquinolones
parenteral
Peyer
thrombophlebitis,
pneu
etc.
be
spots
of
damage),
formation,
organisms from
untreated: triggered
and
antigens
S.
typhi
tissue in
test)
cephalosporins
oral longer
urine, H
vaccine used
of in
U.S.),
and
strain
21
parenteral
vaccine)
23
Pathology
BehavioralScience/Social Sciences
PART
II
|
MICROBIOLOGY
Microbiology KEY
VIGNETTE
Salmonella
CLUES enterica
Salmonella
Subspecies
Other
Than
S.
Subspecies
other
than
typhi
(S.
enteritidis,
typhimurium)
typhi
•
Enterocolitis—inflammatory, ingestion
of
handling
pet
•
Septicemia—very
•
Osteomyelitis—sickle
•
Gram lactose
(
poultry
follows products
Distinguishing •
or
fermenter,
Facultative
gram
MacConkey
reptiles
) bacillus,
Features
young
or
cell
motile, produces
negative
rods,
non–lactose
fermenting
on
EMB,
medium
•
Produces
H2S,
motile
(unlike
•
Speciated
with
biochemical
Shigella)
elderly
disease
non− H2S
Vi
reactions
and
serotyped
with
O,
H,
and
antigens
Reservoir:
enteric
tracts
of
humans
and
domestic
animals,
e.g.,
chickens
and
turtles
Transmission: butter,
raw produce,
chicken
eggs);
and
reptile
eggs pets
in
kitchen;
(snakes,
food
borne
outbreaks
(peanut
turtles)
Pathogenesis •
Sensitive
to
stomach
•
Lowered
stomach
•
Endotoxin
•
Invades
in
cell in →
dose
(antacids
wall;
mucosa
shallow
(infectious
acidity
inflammation
•
acid
no
or
105
organisms)
gastrectomy)
increases
risk
exotoxin
ileocecal
region,
increased
PG
invasive →
to
increased
lamina
propria
cAMP
→
→
loose
diarrhea;
ulceration
Spread
to
most
septicemia
common)
not but
common
may
occur
with with
S.
enterica
subsp.
enteritidis
(the
others
Disease(s) •
Enterocolitis/gastroenteritis
(second
Campylobacter): ally •
bloody,
Septicemia and
enterica
Osteomyelitis:
trait)
Treatment: ampicillin, invasive
Prevention:
23
subsp.
subsp.
dublin):
sickle
cell
common
S.
usually
in
myalgia;
to
osteomyelitis
or of
elderly
paratyphi, when
Salmonella
sickle
cell
disease
(not
(>80%)
on
Hektoen
antibiotics
are generation
agar,
H2S
contraindicated
production
for
cephalosporin,
self
limiting
fluoroquinolone,
gastroenteritis; or
TMP
SMX
disease
properly
it
cases
osteomyelitis; in
after occasion
headache subsp.
young 10%
predisposes of
only
enterica
very
complicates
disease
cause
vomiting; pain;
choleraesuis,
agent
bacterial
nausea;
abdominal
arthritis
causal
patients
third
fever;
or
most
incubation;
enterica
common
culture
hour
stools;
endocarditis
is most
Diagnosis:
loose (S.
S.
occurs; •
6–48
cook
foods
and
wash
hands,
particularly
food
handlers
for
CHAPTER
GENUS:
2
KEY
GARDNERELLA
|
MEDICALLY
VIGNETTE
RELEVANT
BACTERIA
CLUES
Gardnerella Gardnerella
vaginalis •
Female
patient
with
thin
vaginal
discharge Distinguishing
Features
•
Gram
variable
•
Facultative
•
Catalase
rod;
Gram
positive
cell
envelope
anaerobe
negative
Reservoir:
has
human
Transmission:
and
oxidase
negative
•
Post
antibiotic
•
Clue
cells
•
Whiff
test
or
menses
vagina
endogenous
(normal
flora
gets
disturbed,
increased
pH)
Pathogenesis •
Polymicrobial
•
Works
infections synergistically
with
Lactobacillus, •
other
Mobiluncus,
Thought
to
flourish
normal
Bacteroides, when
the
flora
organisms
including
Peptostreptococcus
vaginal
pH
increases,
reduction
of
vaginal
Lactobacillus •
Follows
menses
Disease:
bacterial
adherent
fluid)
Diagnosis: smear;
>4.5,
Whiff
Treatment:
antibiotic
vaginosis
pH for
or
(vaginal
clue
cells
add
KOH
test,
metronidazole
Recall
Question
Ulcers
caused
or
by
therapy
Shigella
odor,
increased
(epithelial
cells
to
and
sample
discharge
covered assess
with for
(thin,
bacteria)
“fishy”
gray,
on
amine
vaginal
odor
clindamycin
species
have
which
of
the
following
characteristics?
A.
Are
B.
Have
C.
Invade
D.
Are
deep
granulomatous
the
vascular
borders
structures
shallow
Answer:
GENUS:
BACTEROIDES
Bacteroides
fragilis
Distinguishing reduced
D
Features:
anaerobic
gram
negative
rods;
modified
LPS
with
activity
23
Pathology
BehavioralScience/Social Sciences
PART
II
|
MICROBIOLOGY
Microbiology KEY
VIGNETTE
Bacteroides
•
Reservoir:
CLUES fragilis
Patient
abdominal
surgery,
trauma,
abdominal
surgery
Septicemia,
•
Gram
peritonitis,
(
) bacilli,
the
genus
endogenous or
Bacteroides
from
bowel
is
defects
predominant
(e.g.,
anaerobe
cytotoxic
drug
use,
cancer),
trauma
Pathogenesis:
modified
reduced •
colon;
Transmission:
with
emergency
human
endotoxin
LPS
(missing
activity;
heptose
capsule
is
and
2
keto
3
deoxyoctonate)
has
antiphagocytic
abscess Diseases:
anaerobic
septicemia,
peritonitis
(often
mixed
infections),
and
abdominal
abscess
Diagnosis:
anaerobes
are
identified
by
biochemical
tests
and
gas
chromatography
Treatment •
Metronidazole,
clindamycin,
or
cefoxitin;
abscesses
should
be
surgically
drained •
Antibiotic
resistance
common
aminoglycosides);
Prevention:
7−10%
prophylactic
Distinguishing
Features:
Transmission:
endogenous
Pathogenesis:
Porphyromonas
Disease:
VIGNETTE
•
or
some
biliary
and
resistant
tract
surgery
spp.
negative
has
cephalosporins,
clindamycin
rods,
gingipains:
anaerobic,
act
as
normal
proteases,
oral
adhesins,
flora
degrades
cytokines
disease
gram
negative
rods
isolated
from
abscess
CLUES metronidazole
pallidum
Sexually IV drug
•
Gram
anaerobic,
Treatment: Treponema
GI
now
Fusobacterium
inflammatory
periodontal
Diagnosis: KEY
and
G,
strains
for
Prevotella,
antibodies
all
antibiotics
Porphyromonas,
IgG
(penicillin
of
active using
Primary:
patient
or
neonate
of
SPIROCHETES
female
nontender,
indurated
genital GENUS:
TREPONEMA
chancre
•
Secondary: colored
•
Tertiary:
maculopapular, rash,
copper
condylomata
gummas
in
cardiovascular
Treponema
pallidum
lata
CNS
Distinguishing
and
•
system
Features
Thin cell
•
Spirillar, by
•
dark
Specific
gram
(
) bacteria
field
or
fluorescent
and
nonspecific
spirochete,
not
reliably
seen
on
Gram
(basically
visualized •
Outer
•
Axial
•
Cannot
•
Is
membrane
has
endotoxin
like
lipids
antibody filaments
=
endoflagella
in
clinical
=
periplasmic
serologic culture
lab;
serodiagnosis
tests
Reservoir:
23
stain
envelope)
an
obligate
human
pathogen
genital
(but
tract
not
intracellular)
flagella
a
gram
negative
CHAPTER
Transmission:
transmitted
Pathogenesis: tendency
Table
II 2
sexually
disease to
chronicity
22.
Stages
characterized
of
or
across
the
by
endarteritis
d
to
3
mo
post
resulting
in
lesions;
chancre;
rated
edge;
to
3
mo
later)
patchy
Fluorescent 50%
weeks
and
both
(30%
of
untreated,
years
lata: and
lesions;
highly
lesion
negative
by
nonspecific
and
specific;
positive
flat,
mucous
wartlike membrane
infectious
Positive
(syphilitic
aortitis,
be
alopecia
perianal
Gummas
of
will serology
Serology
palms
None
later)
microscopy
nonspecific
colored)
includes
Condylomata
Latent
indu heals
(copper
diffuse,
soles,
clean,
3−6
Maculopapular rash,
Tertiary
patients
BACTERIA
strong
contagious;
spontaneously
(1
of
RELEVANT
Diagnosis
Nontender
exposure)
Secondary
MEDICALLY
placenta
Clinical
(10
|
Syphilis
Stage
Primary
2
CNS
granulomas),
serology
Serology:
inflammation
(tabes
cific
specific may
be
tests
Nonspe
negative
dorsalis)
Congenital
(babies
of
IV
drug
users)
Stillbirth,
keratitis,
damage,
notched
8th
asymptomatic
or
widespread
nerve
teeth; with
Serology:
most
born
rhinitis
within
should 3
mo
of
revert birth
to if
negative
uninfected
→
desquamating
maculopapular
rash
Diagnosis •
Visualize
organisms
microscopy •
was
Serology
–
by
2 types
Ab
binds
used
to
–
Specific o
those
with
Lyme
disease;
ABS;
most
nation
(MHA
RPR, syphilis;
specific
so
disease
other
to
usually
fluorescent used
diseases treponemal test);
in
Treponema
mammalian of
ART);
field
titer
may
with lab
mitochondrial
antigen very
is
heart, in
decline FTA
in
primary
tertiary
and
ABS
(VDRL),
(more
cow
sensitive
rapid
recombinant
spirochetes: remain
treponemal
widely
(ART),
antibody bind
earlier;
(dark
tests
source
confirm
research test
treponemal
antibodies; positive
found
(VDRL,
reagin
for
screening
cheap
secondary
venereal
tests
reagin) antigen
not
automated
Earliest and
and
treatment;
microscopy
used)
antibody:
(=
tests
early)
or
longer
treponemes;
screening
Examples: (RPR),
of
cardiolipin: and
in
(except with
no
antibody
membranes
o
but
important:
Nontreponemal o
immunofluorescence
standard
plasma
antigen
reagin
test
(ICE)
expensive) these
positive
tests for
(bejel)
and
antibody pallidum
life,
are
more
but
positive
may absorption
be
specific
positive
in in
(FTA
microhemaggluti
TP)
23
Pathology
BehavioralScience/Social Sciences
PART
II
|
MICROBIOLOGY
Microbiology Treatment •
Benzathine lis
•
penicillin
(no
resistance
Jarisch
increased
occur
during
Borrelia
•
Patient
with
•
Larger
erythema
like
symptoms
•
Gram
Northeast,
•
Microaerophilic
•
Difficult
to
•
Later:
neurologic,
penicillin
spirochete
given
24
BP;
hours
of
rigors,
syphilis
antibiotic
treat
leukopenia;
may
disease
to
contacts;
no
vaccine
available
culture
burgdorferi white
footed
Transmission:
seasons
Midwest,
any
first
syphi
late
negative
Ixodes
•
Ixodes
mice
(nymphs)
(deer)
scapularis
(e.g., •
of
secondary and
ticks
and
and
white
nymphs;
tailed
deer
worldwide
but
(adult
in
3
ticks)
main
areas
of
U.S.:
migrans
Spring/summer
during decreased
and
congenital
spirochetes
Reservoir:
influenza
starts and
primary for
Features
Borrelia
burgdorferi
and
•
CLUES
reaction:
treatment
for G
BORRELIA
Genus
VIGNETTE
form)
penicillin
temperature
benzathine
GENUS:
acting
penicillin);
Herxheimer
ment;
Prevention:
KEY
(long to
West
cardiac,
(I.
Wisconsin,
dammini)
in
Northeast
(e.g.,
Connecticut),
Midwest
Minnesota)
Coast •
Ixodes
•
Late
pacificus
on
West
Coast
(e.g.,
California)
arthritis/ spring/early
summer
incidence
arthralgias Pathogenesis:
B.
primarily
the
Disease:
Lyme
Stage days
Stage (days
1: to
heart,
2:
invades
joints,
disease
early 1
to
burgdorferi and
(#1
localized
vector
(3
month)
early
disseminated
and
arthritis
borne
spreads
Target
enously)
hematog
bloodstream
by
in
immune
to complexes
U.S.)
rash like
Swollen
Bell
symptoms
lymph
Secondary
spreads
via
is caused
disease
Flu
weeks)
(organism
CNS;
skin
palsy,
extreme
nodes
annular
skin
headache, fatigue,
Palpitations,
lesions meningitis,
conjunctivitis arrhythmias,
myocarditis,
pericarditis
Stage (months
23
3:
late to
persistent years)
Arthritis
(mostly
complex
mediated
knees),
immune
involve
CHAPTER
Diagnosis:
serodiagnosis
by
ELISA
(negative
early);
Western
blot
2
|
MEDICALLY
RELEVANT
BACTERIA
for
confirmation
Treatment: (even
doxycycline, in
children);
Prevention:
amoxicillin, ceftriaxone
DEET;
Borrelia
avoid
tick
recurrentis Features:
Transmission: hermsii
(and
Pathogenesis:
body
other
species
antigenic
Disease(s):
relapsing
B.
associated
hermsii);
Diagnosis:
cause
louse
for
of
fever
B.
leads
relapsing
antigen)
not
primary for
arthritis
used
in
U.S.
fever
recurrentis;
to
borne
on
return
soft
of
relapsing
camping
seen
flagellar
ceftriaxone
ticks
from
mice
for
B.
Borrelia)
(tick
with
(OspA
or
hermsii
variation
spirochetes
patient
B.
for
doxycycline
vaccine
spirochetes,
human 13
azithromycin/clarithromycin
secondary;
bites;
and
Distinguishing
or
for
in
dark
fever
rural
field
fever/chills
areas
of
in
U.S.
is
caused
mainly
by
Colorado
microscopy
of
blood
smear
when
is febrile
Treatment:
doxycycline;
Recall
Question
Which
of
the
Jarisch
Herxheimer
following
bacteria
in
cell
osteomyelitis
sickle
A.
Escherichia
coli
B.
Salmonella
enterica
C.
Staphylococcus
D.
Yersinia
reaction
is the
most
possible
common
cause
of
disease?
aureus
enterocolitica
Answer:
GENUS:
LEPTOSPIRA
Leptospira
KEY
interrogans
Distinguishing dark
B
Features:
field
spirochetes
microscopy
but
not
with
light;
can
tight be
terminal
cultured
hooks
in
vitro;
or
coils
aerobic);
(seen
on
VIGNETTE
Leptospira
by
Patients
with
influenza
like
symptoms
serology ±
Reservoir:
interrogans
generally •
diagnosed
CLUES
wild
and
domestic
animals
GI
symptoms
(zoonosis) •
Occupational to
water
or
recreational
exposure
aerosols
Transmission •
Contact branes
•
•
In
U.S.,
with or
animal
enters
via
ational
waters
Hawaii
highest
urine
small
dog,
livestock, (jet
skiers)
incidence
in
breaks
water; in
and or
organism
penetrates
mucous
mem
•
Hawaii
•
Spirochetes
epidermis rat
urine
occupational
through exposure
contaminated (sewer
with
terminal
hoo
recre workers)
state
237
Pathology
BehavioralScience/Social Sciences
PART
II
|
MICROBIOLOGY
Microbiology Pathogenesis:
no
Disease: ±
GI
hepatitis
renal
and
2
23.
Comparison
of
Chlamydiaceae,
Typical (S.
Obligate lar
intracellu
ATP?
Normal
Peptidoglycan cell
*Chlamydial
Rickettsiaceae,
or
not
mud
fever);
treated,
can
influenza progress
test);
culture
(blood,
CSF,
urine)
insensitive
doxycycline
for rat
and
short
term
exposure;
vaccination
of
domestic
control
Mycoplasmataceae
with
Typical
Bacteria
Bacteria
no
Chlamydiaceae
Rickettsiaceae
Mycoplasmataceae
Yes
Yes
No
layer envelope?
peptidoglycan
lacks
ATP
No
ATP
Limited
Normal
Modified*
Normal
peptidoglycan
peptidoglycan
peptidoglycan
muramic
acid
and
is
considered
by
FAMILY:
Family
some
as
modified,
by
others
CHLAMYDIACEAE
Features •
Obligate
•
Elementary
•
Not
•
Cannot
•
Cell
Genera
23
or
if
parasite?
Make
in
swamp
disease);
BACTERIA
aureus)
Mostly
G
pets;
UNUSUAL
II
microscopy
doxycycline
livestock
Table
(Weil
(agglutination
field
penicillin
Prevention:
known
of
intracellular
seen
Medical
•
Chlamydia
•
Chlamydophila
•
Chlamydophila
bacteria
body/reticulate on
Gram
make
wall
like to
failure
dark
Treatment:
factors
disease,
symptoms
serodiagnosis labs;
virulence
(swineherd’s
tract
and
Diagnosis: few
or
leptospirosis
disease
in
toxins
body
stain
ATP
lacks
muramic
Importance trachomatis pneumoniae
psittaci
acid
ATP
Normal
No
as
absent.
ATP
peptidoglycan
available
CHAPTER
Chlamydia
KEY
trachomatis
Distinguishing
Obligate
•
Found
intracellular
•
Infective
•
Not
in
bacterium;
cells
as
form:
seen
on
|
metabolically
inactive,
Gram
cannot
make
active,
replicating
extracellular
stain;
ATP reticulate
elementary
peptidoglycan
layer
bodies
•
Sexually
•
Adult:
body
lacks
muramic
acid
MEDICALLY
VIGNETTE
Chlamydia
Features
•
2
•
RELEVANT
BACTERIA
CLUES
trachomatis
active
patient
urethritis,
or
cervicitis,
inclusion
conjunctivitis
Neonate:
inclusion
neonate
PID,
conjunctivitis/
pneumonia Reservoir:
human
genital
tract
and
eyes •
Transmission: eye
sexual
contact
and
contact
at
birth;
trachoma
is
transmitted
by
hand
from
Africa/Asia,
genital
lymphadenopathy
infection surfaces
Immigrant
to
flies.
Pathogenesis: mucosal
and
of
leads
to
nonciliated
columnar
granulomatous
or
cuboidal
response
and
epithelial
cells
of
•
Cytoplasmic
inclusion
bodies
in
scrapings
damage.
Diseases •
STDs –
in
U.S.
Serotypes
D
herpes –
and
(most are
Nongonococcal tility
–
Inclusion
–
Inclusion
resistance
in
conjunctivitis cough)
L1,
ligament
U.S.,
though
overall
and
major
portion
of
infer
(with
NGU
and
pneumonia
eosinophilic
in
reactive
arthritis)
neonates/infants
(stac
infiltrate
venereum
Serotypes at
in
prevalence) PID,
adults
and/or
with
STD in
reinfection)
conjunctivitis
ulcer
bacterial common cervicitis,
to
Lymphogranuloma
–
common more
urethritis,
(no
cato •
K HPV
site
of
2,
3 (prevalent
contact;
(groove
in
swollen
sign);
Africa,
Asia,
lymph
tertiary
South
nodes
includes
America);
(buboes)
ulcers,
painless
around
fistulas,
inguinal
genital
elephan
tiasis •
Trachoma
–
Leading and
–
cause
of
preventable
infectious
blindness:
serotypes
A,
B,
Ba,
C
Follicular
conjunctivitis
eyelashes
leading
leading
to
probes
in
corneal
to
conjunctival
scarring
and
scarring,
and
inturned
blindness
Diagnosis •
NAAT;
DNA
•
Cytoplasmic
inclusions
antibody
stained
•
Cannot
•
Is
•
Serodiagnosis:
Treatment:
Prevention: systemic
U.S.
be
cultured
scrapings
inert
media
on
in
cultures
azithromycin
, iodine
, or
embryonated
fluorescent
eggs
doxycycline
for for
or
Giemsa
PCR
ELISA
or
erythromycin erythromycin
on
or
cultured
DFA,
and
seen
smear
tissue
(rRNA)
infected
neonatal
mothers conjunctivitis
to
prevent to
prevent
neonatal
disease;
pneumonia
23
Pathology
BehavioralScience/Social Sciences
PART
II
|
MICROBIOLOGY
Microbiology KEY
VIGNETTE
CLUES
GENUS:
CHLAMYDOPHILA
Chlamydophila
•
C.
pneumoniae:
pneumonia:
atypical sputum
intracytoplasmic
•
C.
II 2
24.
Diseases
Caused
by
Chlamydophila
Species
with Organism
C. pneumoniae
Distinguishing
Potential
characteristics
atherosclerosis
Reservoir
Human
C. psittaci
inclusions
psittaci:
exposure
Table
atypical to
pneumonia:
association
with
No
glycogen
in
inclusion
bodies
parrots
Transmission
respiratory
Respiratory
tract
droplets
Birds,
parrots,
(major
U.S.
Dust
of
dried
secretions
Pathogenesis
Intracellular
growth;
smooth lial
muscle, cells,
Disease
and
Atypical nia;
dry
Diagnosis
cough
Psittacosis
bronchitis;
and
(ornithosis);
atypical
pneumonia
prominent
hepatitis,
hoarse
and
with
possible GI
CNS
symptoms
sinusitis
Serology
(complement or
Serology,
microimmuno
fluorescence)
Treatment
pneumo
lobe;
sputum,
fixation
growth
coronary
“walking”
ness;
Intracellular
feces
macrophages
single
scant
bird and
endothe
or
artery
infects
turkeys reservoir)
Cold
agglutinin
negative
Macrolides
and
complement
fixation Cold
agglutinin
negative
Doxycycline
tetracycline
Prevention
GENUS:
Table
II
Group
Rocky Spotted
2 25.
Infections
Disease
Mountain
Scrub
Avoid
birds
RICKETTSIA
Caused
by
Rickettsiae
and
Close
Relatives
Bacterium
Arthropod
Vector
Reservoir
R.
rickettsii
Ticks
R.
prowazekii
Human
R.
typhi
Flea
Rodents
Mites
Rodents
Tick
Small
Ticks,
Host
dogs,
Fever
Epidemic
Endemic
None
Typhus
Typhus
Typhus
Orientia
louse
Humans
tsutsugamushi
Ehrlichiosis
24
E.
chaffeensis
A.
phagocytophilum
mammals
rodents
CHAPTER
Genus
2
|
MEDICALLY
RELEVANT
BACTERIA
Features •
Aerobic,
•
Obligate
gram
bacilli
intracellular
dent
Species
negative
(too
bacteria
small
(do
not
to
stain
make
well
with
sufficient
Gram
ATP
stain)
for
indepen
life)
of
Medical
Importance
•
Rickettsia
rickettsii
•
Rickettsia
prowazekii
•
Rickettsia
typhi
•
Orientia
•
Ehrlichia
spp.
•
Coxiella
burnetii
tsutsugamushi
Rickettsia
(formerly
R.
tsutsugamushi)
KEY
rickettsii
Reservoir:
small
wild
Transmission: ovarian
hard
rodents
and
ticks:
larger
wild
Dermacentor
and
(also
domestic
animals
reservoir
hosts
Rickettsia
(dogs)
because
of
VIGNETTE
•
trans
transmission)
rickettsii
Patient and ankles
Pathogenesis: many
invade
organs
Disease:
including
Rocky
•
Prevalent
•
Headache, and
•
cells
brain,
Mountain
on
liver,
spotted
East
Coast
fever
skin,
fever
(OK,
(38.8
lining
C
capillaries, lungs,
causing
kidney,
and
vasculitis GI
[102.0
NC, F]),
SC);
2–12
malaise,
day
tract
incubation
myalgias,
toxicity,
influenza
petechial
like
rash
and
wrists
that and
symptoms begins
moves
on to
trunk
in
(RMSF)
TN,
with
vomiting,
•
East
Coast
•
Spring/summer
•
Outdoor
•
Weil
mountainous
areas
seasons
exposure
Felix
(+)
confusion
Rash and
endothelial
CLUES
(maculopapular wrists
and
( centripetal •
Ankle
•
Diagnosis
→ then
petechial)
spreads
starts
to
the
(by
trunk,
day
6 of
palms,
illness)
soles,
on
and
ankles
face
rash) and
wrist
may
swelling
be
conjunctivitis,
also
confused
and
occur
by
GI
symptoms,
periorbital
swelling,
stiff
neck,
arthralgias
Diagnosis •
Clinical
symptoms
•
Start
•
Serological
(above)
treatment
and
without IFA
test
tick
bite
laboratory most
widely
confirmation used;
fourfold
increase
in
titer
is
diagnostic •
Weil Proteus
Treatment:
Prevention:
Felix
test
(cross
vulgaris)
doxycycline,
tick
protection
is
no
reaction
of
Rickettsia
longer
used
(but
even
in
and
children
prompt
age
removal;
antigens may
200)
immunity
granulomatous
disease
immunocompromised
normal
polymorphonuclear
multiple
listed number.
flora
leukocytes
subcutaneous
are
number that
cell
not
have
the
to
human
do
disease
organisms
scenarios
and
causes
to
SOME
•
7#
Disease
OBJECTIVE
Answer
These
Infectious
causal
with If
it
the
agents,
abbreviation
specifically
at
the “CA.”
says
“species,”
end
of
This you
the means should
description you give
there should
be
may
be
able
to
a list
species.
35
Pathology
BehavioralScience/Social Sciences
PART
II
|
MICROBIOLOGY
Microbiology Table
II
Type
7
1.
Diseases
of
Infection
Skin,
Mucous
Case
Furuncles,
Membranes,
and
Vignette/Key
Neck,
Underlying
Tissues
Clues
face,
axillae,
Common
buttocks
Causal
Agents
Staphylococcus
aureus
carbuncles Inflamed Acne
vulgaris
follicles
from
Inflammation
of
neck
follicles
down
and
Pseudomonas
sebaceous
aeruginosa
Propionibacterium
(hot
tub
folliculitis)
acnes
glands
Impetigo
Vesicular
lesions
SubQ
Initially
vesicular;
lesions;
catalase
Initially
vesicular
bullae;
catalase
granulomas/
erosion;
but
fish
crusted
Streptococcus
pyogenes
organism
with
longer
lasting
Staphylococcus
aureus
organism
preceded
Tropical
honey
negative
positive
Sometimes
ulcers/cellulitis
skin
by
neurologic
enthusiasts;
pain
Herpes
granulomatous
Mycobacterium
lesion
marinum
(fish
tank
granuloma)
Cellulitis
following
contact
with
saltwater
or
Vibrio
vulnificus
oysters
Mycetoma with tract yellow
(swelling
pain,
Solitary
sinus
or
lymphocutaneous
gardeners
or
lesions,
florists,
sphagnum
rose
Sporothrix
moss
schenckii
(rose
gardener
disease)
formation, granules
in
Subcutaneous ders)
exudate)
Jaw
area,
dental
Malignant
pustule
swelling
multiple
shoul
Bacteria:
associated
→
with or
dark
red
→
black
necrosis
Actinomyces,
Madurella,
extraction,
Pustule →
(extremities,
CA
carious
teeth,
Nocardia,
Fungi:
Pseudallescheria,
Actinomyces
Sporothrix
israelii
“lumpy
jaw”
trauma
fluid
filled,
tumor
eschar
like
surrounded
lesion by
Bacillus
anthracis
red
margin
Ecthyma
Cellulitis
gangrenosum
Blue
green
Dermal
pus,
pain,
Red,
raised
Hot
inflamed
Wounds
grape
skin
odor,
heat
and
facial
tissues. of
above)
like
edema, butterfly
extension ing
(as
burns
rapid
spread.
Pseudomonas
septicemia
Pseudomonas
aeruginosa
Streptococcus
pyogenes
(Erysipelas)
rash
Deeper lesions
tissues or
from
wounds
includ
Variety gram
of (–)
bacteria: rods,
S.
aureus,
Clostridium
S. and
pyogenes, anaerobes
surgical
Surgical
wounds
(clean)
Surgical
wounds
(dirty)—list
Trauma—list
Shallow
Staphylococcus
groups
S.
groups
puncture
aureus,
Clostridium,
wound
through
tennis
shoe
aureus
Enterobacteriaceae,
anaerobes
Enterobacteriaceae,
Pseudomonas
Pseudomonas
aeruginosa
sole
Animal
bites
Various
Pasteurella
Human
Dog
Rat
bites,
fist
fights
Eikenella
bites
multocida
corrodens
Capnocytophaga
bites
canimorsus
Streptobacillus
moniliformis
minus
358
Cat
scratches
with
stellate
resulting granulomas
in
lymphadenopathy
Bartonella
hensela
and
Spirillum
CHAPTER
Table
II 7
Type
2.
Ear,
Nose,
Infection
Acute
Throat,
Upper
Respiratory
Case
otitis
media
System
Vignette/Key
Red,
Common
tympanic pain
ruptures
or
membrane,
goes
if
ear
|
CLINICAL
INFECTIOUS
DISEASE
Infections
Clues
bulging
102–103;
7
away
tubes
fever
if are
H. 5
Agents
Streptococcus
drum patent.
Causal
CA
pneumoniae
influenzae
(often
nontypeable,
recurs) Moraxella
catarrhalis
RSV Rhinovirus
Otitis
externa
Ear
pain—list
of
organisms
NF
often
involved
Often
mixed
Staph
aureus
Candida
otitis
Severe
externa
ing
Sinusitis
Sinus
Oral
cavitary
disease
ear
pain
pain;
low
mouth—overgrowth
chetes
and
throat
Inflamed
tonsils/pharynx,
purulent
and
ach
rior
upset;
papules
grade
BUN; WBC when
cold
fever
of
red
and oral
treponemes
spirochetes)
be
Streptococcus
pyogenes
strep)Rash stom
erythrogenic
poste
Coxsackie
indicates
(group presence
exotoxin
A of
A
on
with
Strep
with
severe
type
a
1–2
Epstein
II
virus
day
cells
gradual
Corynebacterium
diphtheriae
(diphtheria)
laryngotracheitis;
ECG;
Barr
rash;
nasopharyngitis
Exudate
A
fever
lymphadenopathy;
abnormal
media
on
may
base
Downey
obstructive
(toxin).
pts
fever,
membranous
from
otitis
rash
like
(+);
and/or neck
pts,
fever,
lymphadenopathy,
heterophile
acute
Candida
abscesses;
pharynx,
looking
fatigue,
onset
IC
develop
with and
aeruginosa
risk:
which
may
Pseudomonas
deficiency
sandpaper
palate
Throat
Low
coating
lymphadenopathy,
White
Common
C
(water)
for
NF)*
organism)
Fusobacterium
increased
AIDS,
vitamin
cervical
white
(from
(water
(normal
under);
infants,
antibiotics,
spiro
NF)*
Pseudomonas
As
of
thick
base
premature
threaten
bacteria
with
red
life
fever
fusiform
mouth
(painful
diabetic;
grade
Painful
Sore
Sore
in
(from
albicans
Proteus
Malignant
infections:
bull elevated
little bleeds
change
in
profusely
dislodged
Rhinitis,
sneezing,
seasonal
peaks
coughing;
list
CA
with
Rhinoviruses
(summer–fall)
Coronaviruses Human Adenovirus,
(winter–spring) metapneumovirus many
others
35
Pathology
BehavioralScience/Social Sciences
PART
II
|
MICROBIOLOGY
Microbiology Table
Type
II
7
3.
Eye
Infections
Infection
Case
Eyelid
Vignette/Key
Bilateral
Clues
eyelid
swelling,
eosinophilia,
fever,
earlier
GI
Stye;
2
Common
>10%
muscle
Causal
Agents
Trichinella
pain;
Sx
CA
Staphylococcus
aureus
Propionibacterium
Unilateral
inflammation
often to
around
at
eye
Mexico,
or
Central
bite
mouth; or
site
acnes
Trypanosoma
cruzi
travel
South
America
Conjunctivitis
Red
neonate
days Red
itchy
eye(s)/pus;
onset
2–5
itchy
eye(s)/pus;
onset
5–10
days
age
(other
groups)
Red
with
itchy
pain,
Red
pink
Neisseria
gonorrhoeae
Chlamydia D–K
Neonate
Conjunctivitis
Bacterial
“sticky
eye(s),
thin
eye,
trachomatis
Staphylococcus
exudate;
Viral
pink
common
pus;
4
CA
S.
aureus,
aureus
eye:
adenovirus
than
A (all
Haemophilus
sion
eye,
pus,
bodies
serotypes
in
Granulomas
Chorioretinitis
Neonate
Retinopathy keratitis
36
with in
baby
Mom
with
or
IV
drug
inclu CA
U.S.
Chlamydia with
serotypes
pink
Strep,
gram
scarring,
eye blind
Chlamydia serotypes
Strep
influenzae,
H.
abuser
2
CA
Toxoplasma,
Treponema syphilis)
aegyptius
trachomatis D
K
(inclusion
conjunctivi
trachomatis A,
B,
Ba,
C
(trachoma)
serotypes
AIDS;
eye)
[+])
tis)
inturned
corneal CA
of
scrapings;
and
lashes, ness;
presence in
(more
bacterial
group
pneumoniae
Red
(serotypes
U.S.)
eye”
photophobia
eye
CMV
pallidum
(congenital
CHAPTER
Table
II 7
Type
4.
Cardiac
back
Case
endocarditis:
Chills,
fever, pain,
Vignette/Key
Developing arthralgia,
acutely
lesions;
myalgia, ill,
drug
CLINICAL
INFECTIOUS
DISEASE
Clues
a
heart
Common
murmur;
IV
Causal
Agents
Staphylococcus
aureus
Staphylococcus
aureus
user
Janeway
emboli
Not
Subacute
endocarditis:
Fever with
|
Symptoms
Infection
Acute
7
with
weight
sweats,
anorexia,
murmur
may
drug
oral
user
hygiene
or
dental
work
Viridans cases
symptoms onset,
weakness,
present;
Poor
vague
insidious
IV
streptococci in
(55%
native
of
hearts)
fatigue, loss,
night
myalgias; have
emboli,
been
long
splinter
hemorrhages
Gram
neg.
oral
endocarditis
(normal
flora)
HACEK
organisms
(Haemophilus
aphrophilus
Actinobacillus
actinomycetem
comitans Cardiobacterium Eikenella Kingella
Biliary GU
IV
or
urinary
manipulation
drug
tract in
user
infection elderly
hominis corrodens kingae)
Enterococcus
faecalis
men
Staph. Aspergillus Candida
epidermidis (branching
2
cough,
≤5
weeks,
nourished,
giant
cell
influenzae
Parainfluenza
Adults
Foul
baby/child;
with
#1
Chlamydophila
rash
CA
sputum,
often
pts,
smelling
follows
burn
CGD,
malnourishment
pneumonia
and
rium
with
huge
of
pneumoniae
Anaerobes,
mixed
infection
capsule,
+,
Salmon
low
fever,
diffuse
dry
infil
Klebsiella
negative currant
post
catalase
+,
colored
Pneumonia
pneumoniae
bacte jelly
sputum
influenza
Staphylococcus
aureus
coagulase
+
sputum
teens/young
cough;
initially
adults;
non
bad
productive
hacking
Mycoplasma
cough
cause
trates
pneumoniae of
pneumonia
(most in
children) Atypical
with
especially
respiratory
bird
patients
to
East,
Legionella
hepatitis
Chlamydophila
cough;
“ground exudate
progressive
winter,
spp.
drinker
honeycomb
cysts,
Far
smoker,
staccato
biopsy:
staining
exposure
heavy
exposure,
with
x ray;
Travel
distress
conditioning yr,
with
glass” silver
air >50
Atypical
AIDS
Pneumocystis
psittaci
jirovecii
with
hypoxia
early
spring,
SARS
CoV
hypoxia
Spring,
pneumonia
or
cough loss,
with
Over
4
55,
corners
region,
HIV+,
or
exposure
immigrant
to
from
rodents
developing
Hantavirus
Mycobacterium
tuberculosis
country
night
calcifying
Dusty
environment
contamination
with
bird
(Missouri
or
bat
chicken
fecal
Histoplasma
capsulatum
Coccidioides
immitis
Blastomyces
dermatitidi
farmers),
lesions yeasts
packed
Desert
sand,
Rotting South
(Bacteroides,
Peptococcus)
formation
Gram
Atypical:
aspiration,
gram
ventilator,
Abscess
362
risk
Pseudomonas
possible
formation,
anaerobic,
Nosocomial,
sweats,
↑
blindness
Streptococcus
CF
aspiration
abscess
facultative
weight
pneumoniae
influenza
pts,
sputum,
Alcoholic,
chronic
Mycoplasma
pertussis
Measles:
hemorrhagic
alcoholics)
influenzae,
pneumoniae,
Fusobacterium,
Acute
(Croup)
Haemophilus
Bordetella
>9
unvaccinated
(including
virus
RSV
years
afebrile;
pneumonia
Neutropenic
Acute
(epiglottitis)
infiltrates Rusty
cough,
Agents
phonation
years
Poorly
productive
barking
hoarse
infant
With
Pneumonia
sharp
stridor,
Wheezy;
>5
diffuse
Most
unvaccinated
Infant
Typical:
Infections
contaminated Carolina
into
SW
phagocytic
cells
U.S.
wood,
North
and
school
common age
CHAPTER
Table
Type
II 7
6.
Genitourinary
Infection
Urethritis
Tract
7
|
CLINICAL
INFECTIOUS
DISEASE
Infections
Case
Vignette/Key
Gram
negative
Clues
Most
diplococci
in
PMNs
in
urethral
Common
Neisseria
Causal
Agents
gonorrhoeae
exudate
Culture
negative,
Urease
positive,
Flagellated
Cystitis
inclusion
no
bodies
cell
wall
protozoan
Frequent
and
with
painful
Chlamydia
corkscrew
urination,
motility
hematuria,
and
fever
trachomatis
Ureaplasma
urealyticum
Trichomonas
vaginalis
#1
E.
coli,
other
Young,
newly
positive
Pyelonephritis
As
Cervicitis
Friable,
sexually
active
individual;
gram
Staphylococcus
above,
with
flank
inflamed
pain
and
cervix
probes
prominent
with
or
fever
E.
mucopurulent
culture
to
coli,
Staphylococcus
Neisseria
distinguish
gonorrhoeae
trachomatis
odor
Adherent
yellowish
amine
odor
cells
discharge,
in
KOH,
clue
pH cells;
>5,
fishy
gram
negative
(virus)
vaginosis)
nerella
staining
parasite)
simplex
(Bacterial
negative
(non
intracellular
Herpes
itching,
(gram
diplococci)
obligate
discharge
enterics,
saprophyticus
Chlamydia
pain,
negative
Proteus
cocci
discharge;
Vaginal
gram
Pseudomonas,
overgrowth
vaginalis
and
of
Gard
anaerobes
dominate
Vulvovaginitis,
pruritis,
consistency
of
Foamy,
purulent
motile
erythema,
cottage
discharge,
trophozoites
discharge:
Candida
spp.
cheese
many
PMNs
microscopically
and
Trichomonas
vaginalis
(corkscrew
motility)
Pelvic tory
inflamma disease
Adnexal nia,
tenderness, vaginal
cervical tory
Genital
lesions
bleeding,
discharge, movement,
mass
on
follows
menses
Genital
warts
deep
fever; possibly
bimanual
dyspareu
tenderness palpable
exam,
Neisseria from
inflamma
onset
gonorrhoeae
trachomatis
or
or
both
or
a
Chlamydia variety
of
other
organisms
often
Human U.S.
papilloma STD),
virus
Treponema
(most pallidum,
common molluscum
contagiosum
Multiple
painful
Nontender, 2–10
Non
indurated,
Genital tiasis
elephan
Initial develop develop,
ulcer
recurring
healing
Herpes
spontane
Treponema
simplex
virus
pallidum
weeks
painful
adenopathy,
Guinea,
coalescing,
indurated
ously
Soft,
vesicular,
slow
painless
to
ulcer,
gram
papule fistulas; tropics,
papule,
pt
negative
heals;
suppurative
with
Haemophilus
ducreyi
heal
from
Caribbean
intracellular
lymph genital microfilariae
or
New
bacilli
nodes
in
granulomatis
(granuloma
ingui
nale)
enlarge
elephantiasis
Klebsiella
and may
Chlamydia Wuchereria
trachomatis or
Brugia
L1–L3 (filarial
nematodes)
bloodstream
36
Pathology
BehavioralScience/Social Sciences
PART
II
|
MICROBIOLOGY
Microbiology Diarrhea
Dysentery •
Abdominal
•
Usually
cramps,
tenesmus,
associated
with
and
invasive
pus
and
bacterial
blood
in
disease
the
in
the
stool colon
Diarrhea •
Refers
•
Most
to
profuse
watery
commonly
mucosal
feces
associated
surfaces
of
with
the
small
increased intestine
secretion in
of
response
to
fluid
across
a toxin
or
the a
viral
infection •
Table
II 7
7.
Diarrhea
by
No
inflammatory
cells,
usually
no
fever
Intoxication
Common Most
Common
Sources
Ham, salad,
potato
Age
Group
Incubation
Infected
Period
All
1–6
Duration Pathogenesis
hours
cream
Heat
stable
enterotoxin
pastries
produced
in
sits
abd